
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
The development of new or improved vaccines using biotechnological techniques is especially important for developing countries, where traditional means of vaccine manufacture are frequently not available. This volume explores the four main approaches for developing alternative vaccines: the use of live agents; the use of anti-idiotype antibodies; the introduction of DNA or cDNA coding for a protective antigen of the disease agent into a mammalian cell line, into a lower eukaryote, or into an appropriate bacterium; and the synthesis of oligopeptides corresponding to an epitope or a protective antigen of the disease agent.
This volume investigates the technical methodologies and strategic frameworks required to advance vaccine development for resource-limited regions through modern biotechnological innovation. The World Health Organization convened international experts to address the limitations of traditional vaccine manufacturing, proposing a shift toward advanced molecular techniques. The text synthesizes the consensus of this 1985 meeting, establishing a roadmap for utilizing genetic engineering and synthetic biology to combat infectious diseases in developing nations.
What You Will Find
Scope Limits
Experts recognize this publication as a foundational record of the early international effort to standardize biotechnological approaches to global immunization. Readers frequently note the technical density of the prose, which reflects the specialized nature of the scientific discourse present at the Bellagio meeting.
Page Count:
240
Publication Date:
1987-02-26
Publisher:
Oxford University Press
ISBN-10:
019261567X
ISBN-13:
9780192615671
No comments yet. Be the first to share your thoughts!